Insiders / Lyssikatos Joseph P
Lyssikatos Joseph P
CIK 1967150personinsider
Companies
1
First seen
Jan 12, 2026
Last activity
Feb 17, 2026
Companies
| Company | Shares held | Latest |
|---|---|---|
| Enliven Therapeutics, Inc. · ELVN | 758,938 | — |
All securities held
2 positions · latest reported per filing
| Company | Security | Shares |
|---|---|---|
| Enliven Therapeutics, Inc. | Common Stock | 758,938 |
| Enliven Therapeutics, Inc. | Stock Option (right to buy)Derivative | 112,500 |
Activity
InsidersInstitutions
This person's insider trades (Form 4), across every company.| Date | Action | Company | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|
| Jan 9, 2026 | Sell | ELVN Enliven Therapeutics, Inc. Common Stock | $1.46M | -50K -6.13% | 765,188 1.04% of shares | medium |
| Jan 9, 2026 | Sell | ELVN Enliven Therapeutics, Inc. Common Stock | $1.03M | -41K -4.81% | 815,188 1.11% of shares | medium |
| Jan 8, 2026 | Sell | ELVN Enliven Therapeutics, Inc. Common Stock | $842.5K | -34K -3.80% | 856,386 1.17% of shares | medium |
| Jan 20, 2026 | Sell | ELVN Enliven Therapeutics, Inc. Common Stock | $390.3K | -15K -1.91% | 745,188 1.02% of shares | medium |
| Jan 8, 2026 | Sell | ELVN Enliven Therapeutics, Inc. Common Stock | $151.0K | -8K -0.84% | 890,188 1.21% of shares | medium |
| Feb 6, 2026 | Sell | ELVN Enliven Therapeutics, Inc. Common Stock | $145.2K | -5K -0.67% | 740,188 1.01% of shares | medium |
| Jan 20, 2026 | Sell | ELVN Enliven Therapeutics, Inc. Common Stock | $144.8K | -5K -0.72% | 759,697 1.04% of shares | medium |
| Feb 12, 2026 | Grant | ELVN Enliven Therapeutics, Inc. Common Stock | $0 | +19K | 18,750 0.03% of shares | low |
| Feb 12, 2026 | Grant | ELVN Enliven Therapeutics, Inc. Stock Option (right to buy) | — | +113K | 112,500 0.15% of shares | low |